Similar Papers

Paper Title
Journal
Date
Author
Immunohistochemical study of neoangiogenesis markers in squamous cell lung cancer
M M Baudarbekova
Pathologia | VOL. 0
M M BaudarbekovaM M Baudarbekova
02 Sep 2019
Abstract 1985: Ipilimumab and nivolumab induced reactivation of hepatitis B (HBVr) in patient with metastatic squamous cell lung cancer
Leeseul Kim ... Horyun Choi
Cancer Research | VOL. 82
Leeseul Kim, et. al.Leeseul Kim ... Horyun Choi
15 Jun 2022
Long-term response control in a patient with metastatic squamous cell lung cancer after treatment with nivolumab: a case report.
R Pampín-Sánchez ... T Sampedro-Gimeno
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | VOL. 26
R Pampín-Sánchez, et. al.R Pampín-Sánchez ... T Sampedro-Gimeno
08 Apr 2020
LOW YIELD OF CYTOLOGY FOR DIAGNOSIS OF MALIGNANT PLEURAL EFFUSION RELATED TO SQUAMOUS CELL LUNG CANCER
Kevin Davidson ... Rajesh Dash
Chest | VOL. 154
Kevin Davidson, et. al.Kevin Davidson ... Rajesh Dash
01 Oct 2018
View more papers

More From: Annals of Oncology

Paper Title
Journal
Date
Author
Expanding the role of CDK4/6 inhibitors in early breast cancer: insights from the NATALEE trial
Marcela Carausu ... Michail Ignatiadis
Annals of Oncology | VOL. 36
Marcela Carausu, et. al.Marcela Carausu ... Michail Ignatiadis
01 Feb 2025
Table of Contents
-
Annals of Oncology | VOL. 36
--
01 Feb 2025
Editorial Board
-
Annals of Oncology | VOL. 36
--
01 Feb 2025
Table of Contents
-
Annals of Oncology | VOL. 36
--
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.